Published in J Virol Methods on February 01, 1984
Genetic variants of influenza A/Taiwan/1/86 cocirculating in Canada during the winter of 1986 to 1987. J Clin Microbiol (1988) 0.86
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol (1995) 2.20
Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol (1997) 1.88
Characterization of the mRNA of influenza virus. J Virol (1975) 1.71
A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol (1997) 1.63
A murine model for assessment of living attenuated influenza A vaccines. Aust J Exp Biol Med Sci (1980) 1.62
Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol (2005) 1.55
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Biophysical and biochemical characterization of hepatitis A virus. Intervirology (1982) 1.49
The nucleic acid of Sendai virus and ribonucleic acid synthesis in cells infected by Sendai virus. J Gen Virol (1968) 1.36
The sedimentation of influenza virus and its RNA in sucrose density gradients. J Gen Virol (1968) 1.36
Mouse cells expressing human intercellular adhesion molecule-1 are susceptible to infection by coxsackievirus A21. J Virol (1997) 1.23
Live attenuated vaccines against influenza; an historical review. Vaccine (2001) 1.23
Ribonucleic acid polymerase induced in cells infected with Sendai virus. J Virol (1970) 1.22
Participation of DNA-dependent RNA polymerase II in replication of influenza viruses. Nature (1977) 1.22
Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection. J Clin Microbiol (1989) 1.19
The influenza virus genome and its replication. Br Med Bull (1979) 1.19
Nucleic acid of influenza virus. Nature (1966) 1.18
A re-examination of the molecular weight of poliovirus RNA. Biochem Biophys Res Commun (1970) 1.18
Quantitation of antibody to non-hemagglutinating viruses by single radial hemolysis: serological test for human coronaviruses. J Clin Microbiol (1977) 1.17
Genetic recombination between two strains of fowl plague virus: construction of genetic maps. Virology (1979) 1.15
Characterization of the ribonucleic acid of fowl plague virus. Arch Gesamte Virusforsch (1973) 1.15
Evidence that the genome of hepatitis A virus consists of single-stranded RNA. J Virol (1981) 1.14
Characterization of recombinant Eschericha coli 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase: analysis of enzymatic activity and substrate specificity. Biochem Biophys Res Commun (1996) 1.07
Genome organization and transcription strategy in the complex GNS-L intergenic region of bovine ephemeral fever rhabdovirus. J Gen Virol (1997) 1.07
Influenza A antigens on human lymphocytes in vitro and probably in vivo. Nature (1976) 1.06
Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant. Infect Immun (1982) 1.05
Genetic reassortants for identification of the genome segment coding for the bluetongue virus hemagglutinin. J Virol (1987) 1.01
Method for assigning temperature-sensitive mutations of influenza viruses to individual segments of the genome. Virology (1977) 1.00
Further characterization of the genetic map of poliovirus temperature-sensitive mutants. In: strategy of the viral genome. Ciba Found Symp (1971) 1.00
Multiplication of influenza virus in the presence of cordycepin, an inhibitor of cellular RNA synthesis. Nat New Biol (1973) 0.99
The development of Akabane virus-induced congenital abnormalities in cattle. Vet Rec (1988) 0.97
Complex genome organization in the GNS-L intergenic region of Adelaide River rhabdovirus. Virology (1994) 0.93
Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells. Virology (1997) 0.93
The RNA of human coronavirus OC-43. Virology (1977) 0.92
Temperature-sensitive mutants of fowl plague virus: isolation and genetic characterization. Virology (1979) 0.92
The genome of bovine ephemeral fever rhabdovirus contains two related glycoprotein genes. Virology (1992) 0.92
Characterization of human parainfluenza viruses. I. The structural proteins of parainfluenza virus 2 and their synthesis in infected cells. J Gen Virol (1983) 0.91
Structural and antigenic analysis of the nucleoprotein of bovine ephemeral fever rhabdovirus. J Gen Virol (1994) 0.91
The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. Immunology (1984) 0.90
An impending epidemic of bovine congenital deformities. Aust Vet J (1983) 0.89
Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain. Vaccine (2002) 0.88
The nucleic acid of infectious bronchitis virus. Arch Gesamte Virusforsch (1973) 0.88
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. J Immunol (1998) 0.88
Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca. Arch Virol (1987) 0.88
Presence of genomic polyadenylate and absence of detectable virion transcriptase in human coronavirus OC-43. J Gen Virol (1978) 0.87
Hybridization studies of the relationship between influenza virus RNA and cellular DNA. Virology (1976) 0.87
The role of cell culture vaccines in the control of the next influenza pandemic. Expert Opin Biol Ther (2004) 0.87
A study of respiratory infections in a healthy adult population during the 1987 Australian winter. Fam Pract (1993) 0.86
A clearance test in mice using non-adapted viruses to determine the immunogenicity of influenza strains. Arch Virol (1981) 0.84
Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice. J Med Virol (2001) 0.83
Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. J Gen Virol (2000) 0.83
Immunization against influenza by the ocular route. Vaccine (1985) 0.82
Detecting the cause of Lyme disease in Australia. Med J Aust (1991) 0.82
Evaluation of chicken kidney and chicken embryo kidney cultures for the large-scale growth of attenuated influenza virus master strain A/Ann/Arbor/6/60-ca. Vaccine (1985) 0.82
Nucleic acid of infectious laryngotracheitis virus. Nature (1965) 0.82
Adelaide River virus nucleoprotein gene: analysis of phylogenetic relationships of ephemeroviruses and other rhabdoviruses. J Gen Virol (1995) 0.82
Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population. Vaccine (1984) 0.81
An enzyme-linked immunosorbent assay for detection of bovine leukaemia virus p24 antibody in cattle. J Virol Methods (1990) 0.81
Respiratory syncytial virus: a review of the virus, its epidemiology, immune response and laboratory diagnosis. Aust Paediatr J (1986) 0.80
The role of reverse genetics in the development of vaccines against respiratory viruses. Expert Opin Biol Ther (2005) 0.80
Subgrouping of respiratory syncytial virus strains from Australia and Papua New Guinea by biological and antigenic characteristics. Arch Virol (1994) 0.80
A model for determining immunogenic relationships between avian infectious bronchitis viruses. Arch Virol (1990) 0.79
Simultaneous determination of pregnanediol and pregnanolone in urinary extracts by gas chromatography. Clin Chem (1968) 0.79
Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice. Vaccine (1994) 0.79
Western blot analysis of antibody responses to influenza virion proteins. Immunol Cell Biol (1992) 0.78
A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers. Epidemiol Infect (1988) 0.78
RNA polymerase (L) gene and genome terminal sequences of ephemeroviruses bovine ephemeral fever virus and Adelaide River virus indicate a close relationship to vesiculoviruses. Virus Res (2000) 0.78
The topography of RNA synthesis in cells infected with fowl plague virus. J Gen Virol (1974) 0.78
Field evaluations of safety and efficacy of an Australian Marek's disease vaccine. Aust Vet J (2003) 0.78
Differences in the susceptibility of some penaeid prawn species to gill-associated virus (GAV) infection. Dis Aquat Organ (2000) 0.78
The growth of attenuated influenza vaccine donor strains in continuous cell lines. J Virol Methods (2005) 0.77
Some characteristics of a recent virulent isolate of Marek's disease virus. Aust Vet J (1994) 0.77
An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets. J Virol Methods (2003) 0.76
Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses. Vaccine (1997) 0.76
Efficacy of Australian vaccines against recent isolates of avian infectious bronchitis viruses. Aust Vet J (1991) 0.76
A device for the nondestructive decontamination of large volumes of infected egg waste. Appl Environ Microbiol (1985) 0.75
Membrane filtration enzyme immunoassay, a novel, rapid method for measurement of virus-specific immunoglobulins G and M and detection of viral antigens. J Clin Microbiol (1987) 0.75
The effects of UK2054 on the multiplication of influenza viruses. J Hyg (Lond) (1970) 0.75
The antigenicity of the chicken anaemia virus protein VP3 (Apoptin). Avian Pathol (2001) 0.75
Antibody responses to avian encephalomyelitis virus vaccines when administered by different routes. Aust Vet J (1992) 0.75
Further evidence that the nucleic acid of avian encephalomyelitis virus consists of RNA. Avian Dis (1993) 0.75
The nature of the ribonucleic acid synthetized in vitro by Sendai virus-induced ribonucleic acid-dependent ribonucleic acid polymerase. J Gen Microbiol (1970) 0.75
Isolation of serotype 1 Marek's disease viruses from vaccinated Australian flocks. Vet Microbiol (1995) 0.75
Studies on the nature of influenza virus ribonucleic acid. J Gen Microbiol (1970) 0.75
Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus. Aust Vet J (2002) 0.75
Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). Vaccine (1997) 0.75
In vivo metabolism of H3-medroxyprogesterone acetate in pregnant and nonpregnant women and in the fetus. Am J Obstet Gynecol (1966) 0.75
The development and evaluation of two tissue culture-grown Marek's disease challenge viruses. Avian Pathol (1998) 0.75
Fractionation of chick embryo cell RNA on columns of poly-L-lysine coated kieselguhr. Anal Biochem (1970) 0.75
Pathogenesis of avian encephalomyelitis viruses. J Gen Virol (1991) 0.75
Adaptation of Marek's disease virus to the Vero continuous cell line. Vet Microbiol (2001) 0.75
In vitro biosynthetic studies of endocrine tumors. VI. Malignant granulosa cell tumor. Am J Obstet Gynecol (1966) 0.75
Comparison of four methods of determining urinary pregnanediol. Anal Chem (1966) 0.75
Development and application of an ELISA technique for the detection of antibody to avian encephalomyelitis viruses. Res Vet Sci (1989) 0.75
The role of the cell nucleus in the production of influenza viruses. J Med Microbiol (1973) 0.75